Description
Maximune is a brand name for Saquinavir 500 mg Tablets, meticulously crafted by Cipla Ltd., a renowned pharmaceutical company committed to excellence in healthcare. Each tablet of Maximune contains 500 mg of Saquinavir, a potent protease inhibitor indicated for the treatment of HIV infection.
Key Features:
- Active Ingredient: Maximune is formulated with Saquinavir, a potent antiretroviral medication known for its efficacy in inhibiting the protease enzyme essential for HIV replication.
- Strength and Form: Each tablet of Maximune delivers a precise dose of 500 mg of Saquinavir, ensuring optimal therapeutic effect. The tablet form offers convenient and easy administration for patients.
- Comprehensive Packing: Maximune is available in a pack containing 60 tablets, providing an ample supply for continued treatment and management of HIV infection.
Usage Instructions:
- Maximune tablets should be taken orally as directed by a healthcare professional or according to the instructions provided on the packaging.
- Dosage and duration of treatment may vary depending on the patient’s viral load, CD4 cell count, previous treatment history, and other factors. It is essential to follow the prescribed dosage regimen for optimal therapeutic outcomes.
Precautions:
- Maximune should be used in combination with other antiretroviral medications as part of a comprehensive HIV treatment regimen.
- Patients should be closely monitored for signs of immune reconstitution syndrome, drug interactions, and adverse reactions during treatment with Maximune.
- It is important to store Maximune tablets in a cool, dry place away from moisture and heat, and to keep them out of reach of children.
Maximune by Cipla Ltd. offers a reliable and effective solution for the management of HIV infection, providing patients with hope and improved quality of life. Trust Maximune to combat HIV/AIDS with confidence and efficacy.
Reviews
There are no reviews yet.